Detalhe da pesquisa
1.
Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA.
N Engl J Med
; 385(27): 2520-2530, 2021 12 30.
Artigo
Inglês
| MEDLINE | ID: mdl-34708996
2.
Genotype-Guided Dual Antiplatelet Use for Transient Ischemic Attack and Minor Stroke by Imaging Status: Subgroup Analysis of the CHANCE-2 Trial.
Ann Neurol
; 93(4): 783-792, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36571569
3.
Differential effect of ticagrelor versus clopidogrel by homocysteine levels on risk of recurrent stroke: a post hoc analysis of the CHANCE-2 trial.
CMAJ
; 196(5): E149-E156, 2024 Feb 11.
Artigo
Inglês
| MEDLINE | ID: mdl-38346785
4.
Dual Antiplatelet Therapies and Causes in Minor Stroke or Transient Ischemic Attack: A Prespecified Analysis in the CHANCE-2 Trial.
Stroke
; 54(9): 2241-2250, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37548009
5.
Bleeding Risk of Dual Antiplatelet Therapy after Minor Stroke or Transient Ischemic Attack.
Ann Neurol
; 91(3): 380-388, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34951042
6.
Impact of body mass index on efficacy and safety of ticagrelor versus clopidogrel in patients with minor stroke or transient ischemic attack.
CMAJ
; 195(26): E897-E904, 2023 07 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37429630
7.
Ticagrelor-Aspirin Versus Clopidogrel-Aspirin Among CYP2C19 Loss-of-Function Carriers With Minor Stroke or Transient Ischemic Attack in Relation to Renal Function: A Post Hoc Analysis of the CHANCE-2 Trial.
Ann Intern Med
; 175(11): 1534-1542, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36315949
8.
Effect of Hypertension on Efficacy and Safety of Ticagrelor-Aspirin Versus Clopidogrel-Aspirin in Minor Stroke or Transient Ischemic Attack.
Stroke
; 53(9): 2799-2808, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35656824
9.
Association of acute kidney disease with the prognosis of ischemic stroke in the Third China National Stroke Registry.
BMC Nephrol
; 23(1): 188, 2022 05 18.
Artigo
Inglês
| MEDLINE | ID: mdl-35585568
10.
Prognostic Metrics Associated with Inflammation and Atherosclerosis Signaling Evaluate the Burden of Adverse Clinical Outcomes in Ischemic Stroke Patients.
Clin Chem
; 66(11): 1434-1443, 2020 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33276383
11.
Plasma S100A8/A9 Concentrations and Clinical Outcomes of Ischemic Stroke in 2 Independent Multicenter Cohorts.
Clin Chem
; 66(5): 706-717, 2020 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32285094
12.
Serum Dkk-1 (Dickkopf-1) Is a Potential Biomarker in the Prediction of Clinical Outcomes Among Patients With Acute Ischemic Stroke.
Arterioscler Thromb Vasc Biol
; 39(2): 285-293, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30580563
13.
A Comparison of Mortality Prognostic Scores in Ischemic Stroke Patients.
J Stroke Cerebrovasc Dis
; 25(2): 241-7, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26654662
14.
[Management of bilateral benign paroxysmal positional vertigo with Dix-Hallpike test].
Zhonghua Nei Ke Za Zhi
; 53(10): 764-7, 2014 Oct.
Artigo
Chinês
| MEDLINE | ID: mdl-25567145
15.
Effects of remnant cholesterol on the efficacy of genotype-guided dual antiplatelet in CYP2C19 loss-of -function carriers with minor stroke or transient ischaemic attack: a post-hoc analysis of the CHANCE-2 trial.
EClinicalMedicine
; 67: 102357, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38125963
16.
One-Year Outcomes of Early Therapy With Ticagrelor vs Clopidogrel in CYP2C19 Loss-of-Function Carriers With Stroke or TIA Trial.
Neurology
; 102(3): e207809, 2024 Feb 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38181311
17.
Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a subgroup analysis of the CHANCE-2 trial.
Stroke Vasc Neurol
; 2024 Jan 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38286485
18.
Association of CYP2C19 Loss-of-Function Metabolizer Status With Stroke Risk Among Chinese Patients Treated With Ticagrelor-Aspirin vs Clopidogrel-Aspirin: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
JAMA Netw Open
; 6(6): e2317037, 2023 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37279000
19.
Ticagrelor Aspirin vs Clopidogrel Aspirin in CYP2C19 Loss-of-Function Carriers With Minor Stroke or TIA Stratified by Risk Profile.
Neurology
; 100(5): e497-e504, 2023 01 31.
Artigo
Inglês
| MEDLINE | ID: mdl-36535779
20.
Ticagrelor Versus Clopidogrel in Minor Stroke or Transient Ischemic Attack With Intracranial Artery Stenosis: A Post Hoc Analysis of CHANCE-2.
J Am Heart Assoc
; 12(21): e031611, 2023 11 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37889172